Outcome of the 4th CoC Meeting held on 13-01-2025

Nclt Insolvency AdmittedRegulatory & Legal View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.8%Reaction day

₹2.94

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-5.3% vs market

Commodity Chemicals peers, median of 53sector+1.0%-5.7% vs sector

On the reaction day the stock moved 5.3 pts less than Nifty Microcap 250 and 5.7 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.8+0.6-5.3+1.0-5.7

Next day

-8.2+0.5-8.7+0.9-9.1

-3.7+0.8-4.6+0.6-4.4

-4.8+1.2-5.9+0.2-4.9

-4.8+1.5-6.2+0.4-5.2

-5.4+1.6-7.0+1.4-6.8

-11.6+1.8-13.3+0.2-11.8

15d

-15.3+3.3-18.6+1.2-16.5

-17.7+3.1-20.8+3.1-20.8

-10.5+2.3-12.8+0.6-11.2

-19.7+0.2-19.9-4.0-15.7

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 53Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kobo Biotech Ltd is currently under the Corporate Insolvency Resolution Process (CIRP), following an NCLT Hyderabad order dated 13 August 2024 admitting insolvency. On 13 January 2025, the 4th meeting of the Committee of Creditors was held in Mumbai. With 98.86% approval, creditors approved appointing Mrs. Namrata Amol Randeri as the new Resolution Professional at a monthly fee of Rs. 2 lakh plus taxes, replacing the existing RP Mr. Ravindra Chaturvedi. The existing RP was authorized to file the necessary application with NCLT for the replacement. Creditors also approved appointing Advocate M.S. Mano Ranjani at Rs. 40,000 to handle the legal work for this RP replacement.

Likely market impact

This filing confirms the company remains under active insolvency resolution with NCLT, meaning shareholder equity is likely to face significant dilution or extinction depending on the resolution plan. The stock remains a high-risk penny stock with limited trading relevance for retail investors until a resolution plan is approved.